NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

Purchase of these securities is by inquiry. I made the inquiry directly with NWBO. I am a retail shareholder. The “Cs” were offered to me and I received a draft subscription agreement. The price was $16 per preferred share convertible into 25 common or $0.64/share. At the time of my inquiry the market price was about $0.68 so the “discount” was about 5% as the price was “fixed” the previous week..There was a three month holding period up to October 26, 2022. There was no guarantee that sufficient authorized shares would be available at the time of conversion, or for that matter, ever. There were no warrants attached. Nothing was stated as to whether the voting rights attached to the common were immediately available. When I inquired as to how many preferred I could buy, I was told “as many as you want.” The number of shares in my subscription agreement was left blank for me to fill in.

This is really a bad sign. The whole idea of NWBO pursuing a JV is now definitely into the water.

NWBO somehow only understands selling securities to retail holders and has zero creativity in getting finances anywhere else even with excellent data in hand. I wonder what Kristyn Power is doing all day.. wasn't she suppose to prepare to get bigger fish in?

Also, the May 10 conference uin NY has not provided any interest so far by BP, although several were present.

Reality sucks.